Noble Organisation   Report issue

For profit Phase 1 Phase 2
Founded: Sanford NC United States (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2011
NCT01405846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Noble Oil Services

Active Ingredients

Drugs in Phase 2 Trials (1)

gefitinib (iressa) (1 trial)

Drugs in Phase 1 Trials (1)

pfspz (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Head and Neck Neoplasms (Phase 2)

Malaria (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2